ALS market across 8MM set to reach $1.28 bn in 2029: GlobalData
The prevalence of ALS is increasing at a steady rate, in line with population growth in the 8MM, at an AGR of 0.79 per cent
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
disease-modifying therapies
Myasthenia gravis market to generate sales of $6.7 bn across 7MM by 2032: GlobalData
GlobalData identified the influx of several new disease-modifying therapies (DMTs) within the past two years as the main driver of…
Parkinson’s unmet needs present significant opportunity for new entrants: GlobalData
The need for disease-modifying therapies is one of the highest unmet needs and if a curative or disease-modifying agent was…